Literature DB >> 6357523

Urinary mutagenicity assays: a problem arising from the presence of histidine associated growth factors in XAD-2 prepared urine concentrates, with particular relevance to assays carried out using the bacterial fluctuation test.

J F Gibson, P J Baxter, R B Hedworth-Whitty, D Gompertz.   

Abstract

The appearance of mutagenic activity in urine samples from a group of nurses and from unexposed individuals has been investigated using the bacterial fluctuation test. Apparent mutagenic activity was seen in samples from all subjects and did not appear to be related to any specific occupational or environmental exposure. This activity seems to be related to the presence of histidine or histidine-related auxotrophic growth factors in the urine concentrates, not completely removed by the recommended XAD-2 column procedure. It is suggested that the reliance on XAD-2 columns for the removal of histidine may produce spurious results when using this assay to screen populations for exposure to mutagenic chemicals.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6357523     DOI: 10.1093/carcin/4.11.1471

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  12 in total

Review 1.  The risks of handling cytotoxic drugs. I. Methods of testing exposure.

Authors:  G P Kaijser; W J Underberg; J H Beijnen
Journal:  Pharm Weekbl Sci       Date:  1990-12-14

2.  Handling cytotoxics.

Authors:  C J Williams
Journal:  Br Med J (Clin Res Ed)       Date:  1985-11-09

3.  Urinary screening for potentially genotoxic exposures in a chemical industry.

Authors:  G Ahlborg; B Bergström; C Hogstedt; P Einistö; M Sorsa
Journal:  Br J Ind Med       Date:  1985-10

4.  Urine mutagenicity, chromosomal abnormalities and sister chromatid exchanges in lymphocytes of nurses handling cytostatic drugs.

Authors:  I Stucker; A Hirsch; T Doloy; I Bastie-Sigeac; D Hemon
Journal:  Int Arch Occup Environ Health       Date:  1986       Impact factor: 3.015

5.  Monitoring exposure of hospital personnel handling cytostatic drugs and contaminated materials.

Authors:  M P DeMéo; S Mérono; A D DeBaille; A Botta; M Laget; H Guiraud; G Duménil
Journal:  Int Arch Occup Environ Health       Date:  1995       Impact factor: 3.015

6.  Absence of mutagenicity in the urine of autopsy service workers exposed to formaldehyde: factors influencing mutagenicity testing of urine.

Authors:  T H Connor; J B Ward; M S Legator
Journal:  Int Arch Occup Environ Health       Date:  1985       Impact factor: 3.015

7.  Biological effects in a chemical factory with mutagenic exposure. III. Urinary mutagenicity and thioether excretion.

Authors:  L Hagmar; T Bellander; L Persson; A Holmén; R Attewell; B Högstedt; S Skerfving
Journal:  Int Arch Occup Environ Health       Date:  1988       Impact factor: 3.015

8.  Handling of cytostatic drugs and urine mutagenesis.

Authors:  D Poyen; M P De Méo; A Botta; J Gouvernet; G Duménil
Journal:  Int Arch Occup Environ Health       Date:  1988       Impact factor: 3.015

9.  Comparison among five mutagenicity assays in workers producing polyurethane foams.

Authors:  A Holmén; B Akesson; L Hansén; J Frithiof; F Mitelman; A Karlsson; L Persson; H Welinder; S Skerfving; B Högstedt
Journal:  Int Arch Occup Environ Health       Date:  1988       Impact factor: 3.015

10.  Mutagenicity of Chinese traditional medicine Semen Armeniacae amarum by two modified Ames tests.

Authors:  Jianling Jin; Bo Liu; Hui Zhang; Xiao Tian; Yupin Cai; Peiji Gao
Journal:  BMC Complement Altern Med       Date:  2009-11-15       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.